Introduction In their lifetime, patients with follicular lymphoma frequently require multiple
treatments, which have improved their survival over the past few decades. The expected …

Methods: From 570 patients consecutive diagnosed with FL in 2 institutions between 2001
and 2014, we selected 349 patients (median age, 58 years; F/M 188/161; grade 1 74/297 …

Follicular lymphoma (FL) is the second most common lymphoma in the United States and is
characterized by a variable clinical course, disease heterogeneity, and a relapse-and …

Background Few studies have evaluated real-world treatment patterns and survival in
follicular lymphoma (FL). This study evaluated these outcomes among newly diagnosed …

Follicular lymphoma (FL) is the second most common lymphoma, and by virtue of its
chronicity, may be the most prevalent and most treated lymphoma in the United States …

Follicular lymphoma (FL) is the most common indolent lymphoma in the United States with
an incidence of 3.4 patients per 100,000 and an estimated 13,960 new patients diagnosed …

Background The optimal initial therapy of follicular lymphoma (FL) remains unclear. The
aims of this study were to compare primary treatment strategies and assess the impact of …

Background: Current guidelines offer numerous options for initiating therapy in patients with
untreated, advanced stage follicular lymphoma (FL). Selecting among these options that …

Patients with follicular lymphoma (FL) frequently require multiple treatments during their
disease course; however, survival based on lines of treatment remains poorly described in …

Disease overview Follicular lymphoma (FL) is generally an indolent B cell
lymphoproliferative disorder of transformed follicular center B cells. Follicular lymphoma is …